aTyr Pharma Inc (NASDAQ:LIFE)

2.35
Delayed Data
As of 10:30am ET
 -0.099 / -4.04%
Today’s Change
2.30
Today|||52-Week Range
6.50
-32.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-13.4M-12.1M-11.2M-11.5M
 
 
 
 
 
Depreciation226.0K174.0K152.0K161.0K
 
 
 
 
 
Total Other Cash Flow1.2M1.3M1.2M3.1M
 
 
 
 
 
Funds From Operations-11.9M-10.7M-9.8M-8.2M
 
 
 
 
 
Funds From/For Other Operating Expenses2.0M-1.4M-898.0K2.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-13.9M-9.3M-8.9M-10.3M
 
 
 
 
 
 
InvestingIncrease In Investments-11.5M0.00-53.8M-12.4M
 
 
 
 
Decrease In Investments16.2M11.7M14.5M9.0M
 
 
 
 
 
Capital Expenditures-262.0K-449.0K-441.0K-160.0K
 
 
 
 
 
Net Cash Flow Investing4.4M11.3M-39.8M-3.5M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.004.9M0.004.9M
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale25.0K86.0K42.5M226.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing25.0K5.0M42.5M5.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-9.5M7.0M-6.2M-8.7M